Percentage of pediatric patients < 18 years old undergoing non-cardiac cases in which colloids were not administered intraoperatively.

There is a lack of consistent evidence to suggest improved survival with the use of colloids as compared to crystalloids in the surgical population. Because colloids are more expensive than crystalloids, it is recommended that anesthesia providers avoid the use of colloids in most instances.

Patient In Room to Patient out of Room

Pediatric patients < 18 years old who undergo a non-cardiac procedure (as determined by Procedure Type: Cardiac value code: 0)

• Age ≥ 18 years of age
• ASA 5 & 6 Organ Procurement (CPT: 01990)
• Massive Transfusion or blood loss: Defined as volume of 40mL/kg
• Patients that are in prone or Trendelenburg position for more than 4 hours
• Patients with ascites (Concept ID: 10500)

Colloids are not administered during the case.

*This measure will include valid MPOG cases defined by the Is Valid Case phenotype.

Not applicable

Provider(s) signed in at the time of colloid administration.

1. Bhardwaj N. Perioperative fluid therapy and intraoperative blood loss in children. Indian J Anaesth. 2019;63(9):729-736.
2. Sümpelmann R, Kretz FJ, Luntzer R, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth. 2012;22(4):371-378.
3. Bailey AG, McNaull PP, Jooste E, Tuchman JB. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg. 2010;110(2):375-390.
4. Riegger LQ, Voepel-Lewis T, Kulik TJ, et al. Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children. Crit Care Med. 2002;30(12):2649-2654.